Elevance Health reports on October 21, with revenue seen falling and EPS near $4.68

what happened

Elevance Health will publish results for the quarter ended September 30, 2026, on October 21. Earnings Preview, citing LSEG data, reports that 14 analysts expect revenue to slip 1.7% to $49.213 billion from $50.09 billion a year earlier.

The consensus earnings forecast stands at $4.68 per share, unchanged over the past three months. Analyst ratings lean toward buying: 16 buy or strong buy recommendations, 8 holds and no sells. The median 12-month price target is $461.50, roughly 7.8% above the last close of $428.26.

In the previous quarter the company beat expectations, reporting $7.45 per share against an estimate of $6.22, a surprise of 20%.

why it matters

The report matters to investors tracking the US health insurance sector, since results from a large company set a benchmark for the whole industry. Comparing actual figures with the LSEG consensus will show how closely analyst forecasts matched reality. The gap between the share price and the median target also shows how much upside the market has already priced in.

market impact

Elevance Health and US health insurers: the figures will show whether revenue and earnings expectations hold up.

tags

instruments